Companies

Orthofix Medical Inc.

OFIX · CIK 0000884624 · operating

$13.55+0.15%Last updated Mar 2, 6:23 PM

Key Statistics

Valuation

Market Cap$535.78M
P/E
Fwd P/E15.82
PEG
P/S0.65
P/B1.20
EV/EBITDA-108.18
EV/Rev0.81

Profitability

Gross Margin68.83%
Op. Margin-9.90%
Net Margin-11.21%
ROE-20.49%
ROA-10.84%
FCF Margin4.06%

Financial Health

Current Ratio2.45
Debt/Equity0.89
Free Cash Flow$33.35M
Div. Yield

Growth & Other

Revenue Growth2.85%
EPS Growth29.39%
Beta0.76
52W High$18.66
52W Low$10.24

About Orthofix Medical Inc.

Orthofix Medical Inc. operates as a medical device company focused on orthopedic and spinal solutions. The company manufactures and distributes bone growth stimulation devices, spine fixation implants, bone graft substitutes, and surgical navigation technologies. Its product portfolio includes demineralized bone matrices, cellular bone allografts, and the 7D FLASH Navigation System, a platform designed for spinal and cranial surgical procedures.

The company operates through two primary segments. The Global Spine segment encompasses bone growth stimulation devices, spine fixation implants, bone graft substitutes, and navigation technologies for spinal procedures. The Global Limb Reconstruction segment addresses the limb reconstruction market, offering external and internal fixation products for deformity correction, limb lengthening, complex fracture management, and limb preservation, supported by digital technology platforms.

Orthofix maintains a presence across the United States, Italy, the United Kingdom, France, Germany, Brazil, and additional international markets. The company employs approximately 1,605 full-time employees and distributes its products through a network of distributors and sales representatives to hospitals, healthcare organizations, ambulatory surgery centers, and outpatient facilities. Orthofix was founded in 1980 and is headquartered in Lewisville, Texas.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2025$-2.33$-2.33+29.4%
2024$-3.30$-3.30+19.9%
2023$-4.12$-4.12-320.4%
2022$-0.98$-0.98+49.7%
2021$-1.95$-1.95-1600.0%
2020$0.13$0.13-78.3%
2019$0.60$0.61+30.4%
2018$0.46$0.47+475.0%
2017$0.08$0.09+144.4%
2016$-0.18$-0.18-200.0%
2015$0.18$0.18+158.1%
2014$-0.31$-0.31+27.9%
2013$-0.43$-0.43-141.3%
2012$1.04$1.06+60.0%
2011$0.65$0.67

Annual Reports (10-K) · 15 filings

Report DateFiledAccession Number
2025-12-312026-02-240001193125-26-065189SEC ↗
2024-12-312025-02-250000950170-25-026066SEC ↗
2023-12-312024-03-050000950170-24-025877SEC ↗
2022-12-312023-03-060000950170-23-006242SEC ↗
2021-12-312022-02-250001564590-22-006929SEC ↗
2020-12-312021-02-260001564590-21-009214SEC ↗
2019-12-312020-02-240001564590-20-006037SEC ↗
2018-12-312019-02-250001564590-19-004093SEC ↗
2017-12-312018-02-260001564590-18-003256SEC ↗
2016-12-312017-02-270001564590-17-002569SEC ↗
2015-12-312016-02-290001564590-16-013722SEC ↗
2014-12-312015-04-290001564590-15-003012SEC ↗
2013-12-312014-03-310001193125-14-122624SEC ↗
2012-12-312013-03-010001193125-13-087561SEC ↗
2011-12-312012-02-290001104659-12-014637SEC ↗